FORZINITY

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Sep 19, 2025

   9 mo ago

2. Today

3. Patent 7576061 expires

   Listed drug substance patent expiration.

   Jan 20, 2027

   in 7 mo

4. Exclusivity ends · NCE

   New chemical entity exclusivity (5 years)

   Sep 19, 2030

   in 4 yr 4 mo

5. Exclusivity ends · ODE-551

   Orphan-drug exclusivity (7 years)

   Sep 19, 2032

   in 6 yr 4 mo

6. Patent 11083771 expires

   Listed method-of-use patent (U-4277) expiration.

   Feb 28, 2034

   in 7 yr 10 mo

7. Patent 11083772 expires

   Listed method-of-use patent (U-4277) expiration.

   Feb 28, 2034

   in 7 yr 10 mo

8. Patent 11771734 expires

   Listed method-of-use patent (U-4277) expiration.

   Feb 28, 2034

   in 7 yr 10 mo

9. Patent 12268724 expires

   Listed method-of-use patent (U-4277) expiration.

   Feb 28, 2034

   in 7 yr 10 mo

10. Patent 9687519 expires

    Listed method-of-use patent (U-4277) expiration.

    Feb 28, 2034

    in 7 yr 10 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (2)

• NCENew chemical entity exclusivity (5 years)

  Sep 19, 2030

  in 4 yr 4 mo

• ODE-551Orphan-drug exclusivity (7 years)

  Sep 19, 2032

  in 6 yr 4 mo

Listed patents (6)